Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70579 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Emre Özer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Menorrhagia, Anovulation, von Willebrand Diseases, Blood Coagulation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the frequency, etiology, and clinical characteristics of bleeding disorders (BD) in adolescents with heavy menstrual bleeding (HMB) and evaluate treatment outcomes.
Methods
This retrospective study analyzed 515 adolescents (10–19 years) presenting with abnormal uterine bleeding (AUB) at a multidisciplinary clinic. After excluding 24 with chronic diseases, 491 patients were categorized as: anovulatory HMB (HMB‐An, n = 305), BD ( n = 40), and non‐HMB anovulatory cycles ( n = 146). All HMB patients underwent hemostatic and endocrine assessments, with coagulation and platelet function tests when indicated.
Results
Among 345 HMB patients, 40 (11.6%) had BD. The most common cause was von Willebrand disease (vWD) (12/40, 30%), followed by coagulation factor deficiencies (11/40, 27.5%), thrombocytopenia (8/40, 20%), and platelet function defects (6/40, 15%). Hospitalization rates were higher in BD than HMB‐An (25% vs 16%). Combined oral contraceptives (0.03 mg ethinyl estradiol + 0.15 mg levonorgestrel, tapered over 7–10 days) controlled bleeding in 85% of acute‐phase HMB within a median of 3 days. VWD patients had a milder course, with fewer rates of HMB at menarche, prolonged bleeding, and transfusion needs.
Conclusion
Bleeding disorders should be considered in all adolescents with HMB, particularly when hemoglobin is ≤10 g/dL. Persistent bleeding despite treatment requires re‐evaluation, even if initial results are normal, with special attention to platelet dysfunction. Early recognition and prompt initiation of hormonal therapy, especially combined oral contraceptives, effectively reduce hospitalizations, transfusions, and improve quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatrics, Division of Adolescent Health, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Hematology, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Pediatric Endocrinology, Ankara Yıldırım Beyazıt University, Medical School, Ankara, Turkey.
ORCID-Profile: Emre Özer, Alkım Öden Akman, Fatma Burçin Kurtipek, Gönül Büyükyılmaz, Abdurrahman Bitkay, Keziban Toksoy Adıgüzel, Namık Yaşar Özbek, Mehmet Boyraz, Fatih Gürbüz
Zitieren
APA
Özer, E., Akman, A. Ö., Kurtipek, F. B., Büyükyılmaz, G., Bitkay, A., Toksoy Adıgüzel, K., Özbek, N. Y., Boyraz, M., & Gürbüz, F. (2026). Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70579
Vancouver
Özer E, Akman AÖ, Kurtipek FB, Büyükyılmaz G, Bitkay A, Toksoy Adıgüzel K, et al. Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70579
BibTeX
@article{zer2026,
author = {Özer, Emre and Akman, Alkım Öden and Kurtipek, Fatma Burçin and Büyükyılmaz, Gönül and Bitkay, Abdurrahman and Toksoy Adıgüzel, Keziban and Özbek, Namık Yaşar and Boyraz, Mehmet and Gürbüz, Fatih},
title = {Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70579}
}
EUVIMED